Literature DB >> 9308753

Electrospray ionisation analysis of human fibrinogen.

S O Brennan1.   

Abstract

Fibrinogen, a 340 kDa glycoprotein, was purified from human plasma, separated into its constituent polypeptide chains and analyzed by electrospray ionization mass spectrometry. Six individual plasmas were examined, and whilst the A alpha chain appeared homogeneous, the Bbeta and gamma chains were heterogeneous with the predominant form of each lacking a single sialic acid residue. The mean molecular masses of the dominant gamma and Bbeta isoforms were 48,366 and 54,200 Da with standard deviations of 10 and 12 Da respectively compared to predictions, based on amino acid and carbohydrate sequences, of 48,368 and 54,213 Da. The mean mass of the A alpha chain was 66,196 Da but this showed significantly more variation with a standard deviation of 64 Da. This probably reflects genetic and/or post-translational differences, since there is non-stoichiometric phosphorylation at Ser 3 and 345 and the expected residue weight of the non-phosphorylated chain is 66,132 Da. After treatment with thrombin the fibrin beta chain showed a decrease in mass of 1542 Da in good agreement with the expected decrease of 1535 Da resulting from loss of the B peptide. Loss of the A peptide from the alpha chain resulted in a decrease of 1546 Da compared to an expected loss of 1519 Da for non-phosphorylated A peptide. On prolonged thrombin incubations factor XIII induced gamma-gamma dimers were observed at 96,896 Da.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9308753

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  9 in total

1.  Mutant fibrinogen cleared from the endoplasmic reticulum via endoplasmic reticulum-associated protein degradation and autophagy: an explanation for liver disease.

Authors:  Kristina B Kruse; Amy Dear; Erin R Kaltenbrun; Brandan E Crum; Peter M George; Stephen O Brennan; Ardythe A McCracken
Journal:  Am J Pathol       Date:  2006-04       Impact factor: 4.307

2.  High-level expression and preparation of recombinant human fibrinogen as biopharmaceuticals.

Authors:  Masaki Hirashima; Takayuki Imamura; Kentaro Yano; Ryoichi Kawamura; Akihiro Meta; Yoshiyuki Tokieda; Toshihiro Nakashima
Journal:  J Biochem       Date:  2015-10-15       Impact factor: 3.387

3.  Fibrinogen brescia: hepatic endoplasmic reticulum storage and hypofibrinogenemia because of a gamma284 Gly-->Arg mutation.

Authors:  S O Brennan; J Wyatt; D Medicina; F Callea; P M George
Journal:  Am J Pathol       Date:  2000-07       Impact factor: 4.307

4.  Immobilization of aminophenylboronic acid on magnetic beads for the direct determination of glycoproteins by matrix assisted laser desorption ionization mass spectrometry.

Authors:  Jeong Heon Lee; Yangsun Kim; Mi Young Ha; Eun Kyu Lee; Jaebum Choo
Journal:  J Am Soc Mass Spectrom       Date:  2005-09       Impact factor: 3.109

5.  Molecular mechanisms involved in the resistance of fibrin to clot lysis by plasmin in subjects with type 2 diabetes mellitus.

Authors:  E J Dunn; H Philippou; R A S Ariëns; P J Grant
Journal:  Diabetologia       Date:  2006-03-16       Impact factor: 10.122

6.  Characterization of non-covalent oligomers of proteins treated with hypochlorous acid.

Authors:  Anna L P Chapman; Christine C Winterbourn; Stephen O Brennan; T William Jordan; Anthony J Kettle
Journal:  Biochem J       Date:  2003-10-01       Impact factor: 3.857

7.  High prevalence of dysfibrinogenemia among patients with chronic thromboembolic pulmonary hypertension.

Authors:  Timothy A Morris; James J Marsh; Peter G Chiles; Marisa M Magaña; Ni-Cheng Liang; Xavier Soler; Daniel J Desantis; Debby Ngo; Virgil L Woods
Journal:  Blood       Date:  2009-05-06       Impact factor: 22.113

8.  Deletion of five residues from the coiled coil of fibrinogen (Bbeta Asn167_Glu171del) associated with bleeding and hypodysfibrinogenemia.

Authors:  Stephen O Brennan; Ryan L Davis; Robin Lowen; Anna Ruskova
Journal:  Haematologica       Date:  2009-02-19       Impact factor: 9.941

9.  Variation of fibrinogen oligosaccharide structure in the acute phase response: Possible haemorrhagic implications.

Authors:  Stephen O Brennan
Journal:  BBA Clin       Date:  2015-03-04
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.